[go: up one dir, main page]

(Q42244116)

English

Anti-CD2 receptor and anti-CD2 ligand (CD48) antibodies synergize to prolong allograft survival

scientific article published on January 1994

In more languages
default for all languages
No label defined

No description defined

Statements

Anti-CD2 receptor and anti-CD2 ligand (CD48) antibodies synergize to prolong allograft survival (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit